Related Experiment Video
Updated: Jul 14, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Deficient chaperone-mediated autophagy facilitates LPS-induced microglial activation via regulation of the
Jin Wu1, Yingying Han1, Hao Xu1
1Laboratory of Molecular Neuropathology, Department of Pharmacology, Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, Jiangsu, China.
Abstract:
Neuroinflammation is a pathological change that is involved in the progression of Parkinson's disease. Dysfunction of chaperone-mediated autophagy (CMA) has proinflammatory effects. However, the mechanism by which CMA mediates inflammation and whether CMA affects microglia and microglia-mediated neuronal damage remain to be elucidated. In the present study, we found that LAMP2A, a limiting protein for CMA, was decreased in lipopolysaccharide (LPS)-treated primary microglia. Activation of CMA by the activator CA significantly repressed LPS-induced microglial activation, whereas CMA dysfunction exacerbated microglial activation. We further identified that the protein p300 was a substrate of CMA. Degradation of p300 by CMA reduced p65 acetylation, thereby inhibiting the transcription of proinflammatory factors and the activation of the NLRP3 inflammasome. Furthermore, CA pretreatment inhibited microglia-mediated inflammation and, in turn, attenuated neuronal death in vitro and in vivo. Our findings suggest repressive effects of CMA on microglial activation through the p300-associated NF-κB signaling pathway, thus uncovering a mechanistic link between CMA and neuroinflammation.
Insights
Chaperone-mediated autophagy (CMA) activation suppresses neuroinflammation by degrading p300, reducing microglial activation and neuronal damage in Parkinson's disease models.
Area of Science:
- Neuroscience
- Cell Biology
- Immunology
Background:
- Neuroinflammation is a key factor in Parkinson's disease progression.
- Chaperone-mediated autophagy (CMA) dysfunction is linked to pro-inflammatory effects.
- The precise role of CMA in microglial activation and neuroinflammation requires clarification.
Purpose of the Study:
- To investigate the mechanism by which CMA modulates microglial activation and neuroinflammation.
- To determine if CMA influences microglia-mediated neuronal damage.
- To explore the therapeutic potential of CMA activation in Parkinson's disease.
Main Methods:
- Assessed LAMP2A levels in lipopolysaccharide (LPS)-treated primary microglia.
- Utilized a CMA activator (CA) to modulate CMA activity.
- Identified p300 as a CMA substrate using proteomic analysis.
- Examined p65 acetylation and NLRP3 inflammasome activation.
- Evaluated neuronal death in vitro and in vivo models.
Main Results:
- LAMP2A, a crucial CMA protein, was reduced in LPS-treated microglia.
- CMA activation by CA repressed LPS-induced microglial activation.
- CMA dysfunction exacerbated microglial activation.
- CMA degrades p300, reducing p65 acetylation and inhibiting pro-inflammatory factors and NLRP3 inflammasome activation.
- CA pretreatment reduced microglia-mediated inflammation and attenuated neuronal death.
Conclusions:
- CMA activation suppresses microglial activation via the p300-NF-κB pathway.
- This study reveals a novel mechanism linking CMA to neuroinflammation in Parkinson's disease.
- Targeting CMA represents a potential therapeutic strategy for neuroinflammatory conditions.
Related Concept Videos
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Regulation of the Unfolded Protein Response
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Export of Misfolded Proteins out of the ER
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

